First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19
TARRYTOWN, N.Y. and PARIS, March 30, 2020 /PRNewswire/ — Phase 2/3 trial initiated in Italy, Spain, Germany, France, Japan, Canada and Russia and is enrolling patients immediately Kevzara inhibits IL-6, which may play a role in driving the inflammatory immune response that causes acute…
Comments Off on First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19